186 related articles for article (PubMed ID: 36575558)
41. WGCNA Identifies Translational and Proteasome-Ubiquitin Dysfunction in Rett Syndrome.
Haase F; Gloss BS; Tam PPL; Gold WA
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576118
[TBL] [Abstract][Full Text] [Related]
42. MeCP2 SUMOylation rescues Mecp2-mutant-induced behavioural deficits in a mouse model of Rett syndrome.
Tai DJ; Liu YC; Hsu WL; Ma YL; Cheng SJ; Liu SY; Lee EH
Nat Commun; 2016 Feb; 7():10552. PubMed ID: 26842955
[TBL] [Abstract][Full Text] [Related]
43. CREB Signaling Is Involved in Rett Syndrome Pathogenesis.
Bu Q; Wang A; Hamzah H; Waldman A; Jiang K; Dong Q; Li R; Kim J; Turner D; Chang Q
J Neurosci; 2017 Mar; 37(13):3671-3685. PubMed ID: 28270572
[TBL] [Abstract][Full Text] [Related]
44. Reduced expression of MECP2 affects cell commitment and maintenance in neurons by triggering senescence: new perspective for Rett syndrome.
Squillaro T; Alessio N; Cipollaro M; Melone MA; Hayek G; Renieri A; Giordano A; Galderisi U
Mol Biol Cell; 2012 Apr; 23(8):1435-45. PubMed ID: 22357617
[TBL] [Abstract][Full Text] [Related]
45. miR-199a Links MeCP2 with mTOR Signaling and Its Dysregulation Leads to Rett Syndrome Phenotypes.
Tsujimura K; Irie K; Nakashima H; Egashira Y; Fukao Y; Fujiwara M; Itoh M; Uesaka M; Imamura T; Nakahata Y; Yamashita Y; Abe T; Takamori S; Nakashima K
Cell Rep; 2015 Sep; 12(11):1887-901. PubMed ID: 26344767
[TBL] [Abstract][Full Text] [Related]
46. Transcriptional regulation in pluripotent stem cells by methyl CpG-binding protein 2 (MeCP2).
Tanaka Y; Kim KY; Zhong M; Pan X; Weissman SM; Park IH
Hum Mol Genet; 2014 Feb; 23(4):1045-55. PubMed ID: 24129406
[TBL] [Abstract][Full Text] [Related]
47. Quantitative proteomic analysis of Rett iPSC-derived neuronal progenitors.
Varderidou-Minasian S; Hinz L; Hagemans D; Posthuma D; Altelaar M; Heine VM
Mol Autism; 2020 May; 11(1):38. PubMed ID: 32460858
[TBL] [Abstract][Full Text] [Related]
48. Generation and Characterization of a Human Neuronal In Vitro Model for Rett Syndrome Using a Direct Reprogramming Method.
Huber A; Sarne V; Beribisky AV; Ackerbauer D; Derdak S; Madritsch S; Etzler J; Huck S; Scholze P; Gorgulu I; Christodoulou J; Studenik CR; Neuhaus W; Connor B; Laccone F; Steinkellner H
Stem Cells Dev; 2024 Mar; 33(5-6):128-142. PubMed ID: 38164119
[TBL] [Abstract][Full Text] [Related]
49. Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation.
Jentarra GM; Olfers SL; Rice SG; Srivastava N; Homanics GE; Blue M; Naidu S; Narayanan V
BMC Neurosci; 2010 Feb; 11():19. PubMed ID: 20163734
[TBL] [Abstract][Full Text] [Related]
50. Selective preservation of MeCP2 in catecholaminergic cells is sufficient to improve the behavioral phenotype of male and female Mecp2-deficient mice.
Lang M; Wither RG; Brotchie JM; Wu C; Zhang L; Eubanks JH
Hum Mol Genet; 2013 Jan; 22(2):358-71. PubMed ID: 23077217
[TBL] [Abstract][Full Text] [Related]
51. The protocadherins, PCDHB1 and PCDH7, are regulated by MeCP2 in neuronal cells and brain tissues: implication for pathogenesis of Rett syndrome.
Miyake K; Hirasawa T; Soutome M; Itoh M; Goto Y; Endoh K; Takahashi K; Kudo S; Nakagawa T; Yokoi S; Taira T; Inazawa J; Kubota T
BMC Neurosci; 2011 Aug; 12():81. PubMed ID: 21824415
[TBL] [Abstract][Full Text] [Related]
52. Regulation mechanism and research progress of MeCP2 in Rett syndrome.
Yang W; Pan H
Yi Chuan; 2014 Jul; 36(7):625-30. PubMed ID: 25076025
[TBL] [Abstract][Full Text] [Related]
53. Restoring Wnt6 signaling ameliorates behavioral deficits in MeCP2 T158A mouse model of Rett syndrome.
Hsu WL; Ma YL; Liu YC; Tai DJC; Lee EHY
Sci Rep; 2020 Jan; 10(1):1074. PubMed ID: 31974426
[TBL] [Abstract][Full Text] [Related]
54. Excitatory synapses are stronger in the hippocampus of Rett syndrome mice due to altered synaptic trafficking of AMPA-type glutamate receptors.
Li W; Xu X; Pozzo-Miller L
Proc Natl Acad Sci U S A; 2016 Mar; 113(11):E1575-84. PubMed ID: 26929363
[TBL] [Abstract][Full Text] [Related]
55. Generation and analysis of the Rett syndrome-associated MeCP2- null rat model.
Zhai W; Hu HX; Le L; Zhuang FF; Wang KZ; Zhao Y; Wang K; Liu XM; Sun D; Wang XY; Kuang SH; Hu KP
Yi Chuan; 2016 Nov; 38(11):1004-1011. PubMed ID: 27867150
[TBL] [Abstract][Full Text] [Related]
56. Disruption of MeCP2 attenuates circadian rhythm in CRISPR/Cas9-based Rett syndrome model mouse.
Tsuchiya Y; Minami Y; Umemura Y; Watanabe H; Ono D; Nakamura W; Takahashi T; Honma S; Kondoh G; Matsuishi T; Yagita K
Genes Cells; 2015 Dec; 20(12):992-1005. PubMed ID: 26456390
[TBL] [Abstract][Full Text] [Related]
57. Loss of
Morello N; Schina R; Pilotto F; Phillips M; Melani R; Plicato O; Pizzorusso T; Pozzo-Miller L; Giustetto M
eNeuro; 2018; 5(5):. PubMed ID: 30255129
[TBL] [Abstract][Full Text] [Related]
58. Mirtazapine treatment in a young female mouse model of Rett syndrome identifies time windows for the rescue of early phenotypes.
Flores Gutiérrez J; Natali G; Giorgi J; De Leonibus E; Tongiorgi E
Exp Neurol; 2022 Jul; 353():114056. PubMed ID: 35358499
[TBL] [Abstract][Full Text] [Related]
59. Investigation of Rett syndrome using pluripotent stem cells.
Dajani R; Koo SE; Sullivan GJ; Park IH
J Cell Biochem; 2013 Nov; 114(11):2446-53. PubMed ID: 23744605
[TBL] [Abstract][Full Text] [Related]
60. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice.
Chen RZ; Akbarian S; Tudor M; Jaenisch R
Nat Genet; 2001 Mar; 27(3):327-31. PubMed ID: 11242118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
